BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33942433)

  • 1. New cases that expand the genotypic and phenotypic spectrum of Congenital NAD Deficiency Disorder.
    Szot JO; Slavotinek A; Chong K; Brandau O; Nezarati M; Cueto-González AM; Patel MS; Devine WP; Rego S; Acyinena AP; Shannon P; Myles-Reid D; Blaser S; Mieghem TV; Yavuz-Kienle H; Skladny H; Miller K; Riera MDT; Martínez SA; Tizzano EF; Dupuis L; James Stavropoulos D; McNiven V; Mendoza-Londono R; Elliott AM; ; Phillips RS; Chapman G; Dunwoodie SL
    Hum Mutat; 2021 Jul; 42(7):862-876. PubMed ID: 33942433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bi-allelic Mutations in NADSYN1 Cause Multiple Organ Defects and Expand the Genotypic Spectrum of Congenital NAD Deficiency Disorders.
    Szot JO; Campagnolo C; Cao Y; Iyer KR; Cuny H; Drysdale T; Flores-Daboub JA; Bi W; Westerfield L; Liu P; Leung TN; Choy KW; Chapman G; Xiao R; Siu VM; Dunwoodie SL
    Am J Hum Genet; 2020 Jan; 106(1):129-136. PubMed ID: 31883644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD Deficiency, Congenital Malformations, and Niacin Supplementation.
    Shi H; Enriquez A; Rapadas M; Martin EMMA; Wang R; Moreau J; Lim CK; Szot JO; Ip E; Hughes JN; Sugimoto K; Humphreys DT; McInerney-Leo AM; Leo PJ; Maghzal GJ; Halliday J; Smith J; Colley A; Mark PR; Collins F; Sillence DO; Winlaw DS; Ho JWK; Guillemin GJ; Brown MA; Kikuchi K; Thomas PQ; Stocker R; Giannoulatou E; Chapman G; Duncan EL; Sparrow DB; Dunwoodie SL
    N Engl J Med; 2017 Aug; 377(6):544-552. PubMed ID: 28792876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinamide Adenine Dinucleotide Deficiency and Its Impact on Mammalian Development.
    Dunwoodie SL; Bozon K; Szot JO; Cuny H
    Antioxid Redox Signal; 2023 Dec; 39(16-18):1108-1132. PubMed ID: 37300479
    [No Abstract]   [Full Text] [Related]  

  • 5. A metabolic signature for NADSYN1-dependent congenital NAD deficiency disorder.
    Szot JO; Cuny H; Martin EM; Sheng DZ; Iyer K; Portelli S; Nguyen V; Gereis JM; Alankarage D; Chitayat D; Chong K; Wentzensen IM; Vincent-Delormé C; Lermine A; Burkitt-Wright E; Ji W; Jeffries L; Pais LS; Tan TY; Pitt J; Wise CA; Wright H; Andrews ID; Pruniski B; Grebe TA; Corsten-Janssen N; Bouman K; Poulton C; Prakash S; Keren B; Brown NJ; Hunter MF; Heath O; Lakhani SA; McDermott JH; Ascher DB; Chapman G; Bozon K; Dunwoodie SL
    J Clin Invest; 2024 Feb; 134(4):. PubMed ID: 38357931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD deficiency due to environmental factors or gene-environment interactions causes congenital malformations and miscarriage in mice.
    Cuny H; Rapadas M; Gereis J; Martin EMMA; Kirk RB; Shi H; Dunwoodie SL
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3738-3747. PubMed ID: 32015132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruptive
    Lin J; Zhao L; Zhao S; Li S; Zhao Z; Chen Z; Zheng Z; Shao J; Niu Y; Li X; Zhang JT; Wu Z; Wu N
    Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult patient diagnosed with NADSYN1 associated congenital NAD deficiency and analysis of NAD levels to be published in: European Journal of Medical Genetics.
    Erbs E; Brasen CL; Lund AM; Rasmussen M
    Eur J Med Genet; 2023 Mar; 66(3):104698. PubMed ID: 36649848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Alterations in NADSYN1-Deficient Cells.
    Meijer NWF; Gerrits J; Zwakenberg S; Zwartkruis FJT; Verhoeven-Duif NM; Jans JJM
    Metabolites; 2023 Dec; 13(12):. PubMed ID: 38132878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical heterogeneity of NADSYN1-associated VCRL syndrome.
    Aubert-Mucca M; Janel C; Porquet-Bordes V; Patat O; Touraine R; Edouard T; Michot C; Tessier A; Cormier-Daire V; Attie-Bitach T; Baujat G
    Clin Genet; 2023 Jul; 104(1):114-120. PubMed ID: 36951206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ Protection by Caloric Restriction Depends on Activation of the De Novo NAD+ Synthesis Pathway.
    Späth MR; Hoyer-Allo KJR; Seufert L; Höhne M; Lucas C; Bock T; Isermann L; Brodesser S; Lackmann JW; Kiefer K; Koehler FC; Bohl K; Ignarski M; Schiller P; Johnsen M; Kubacki T; Grundmann F; Benzing T; Trifunovic A; Krüger M; Schermer B; Burst V; Müller RU
    J Am Soc Nephrol; 2023 May; 34(5):772-792. PubMed ID: 36758124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Homozygous Deletion of Exon 5 of
    Schüle I; Berger U; Matysiak U; Ruzaike G; Stiller B; Pohl M; Spiekerkoetter U; Lausch E; Grünert SC; Schmidts M
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesizing and salvaging NAD: lessons learned from Chlamydomonas reinhardtii.
    Lin H; Kwan AL; Dutcher SK
    PLoS Genet; 2010 Sep; 6(9):e1001105. PubMed ID: 20838591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal heterozygosity of Slc6a19 causes metabolic perturbation and congenital NAD deficiency disorder in mice.
    Cuny H; Bozon K; Kirk RB; Sheng DZ; Bröer S; Dunwoodie SL
    Dis Model Mech; 2023 May; 16(5):. PubMed ID: 36374036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STUDIES ON THE BIOSYNTHESIS OF NICOTINAMIDE ADENINE DINUCLEOTIDE. II. A ROLE OF PICOLINIC CARBOXYLASE IN THE BIOSYNTHESIS OF NICOTINAMIDE ADENINE DINUCLEOTIDE FROM TRYPTOPHAN IN MAMMALS.
    IKEDA M; TSUJI H; NAKAMURA S; ICHIYAMA A; NISHIZUKA Y; HAYAISHI O
    J Biol Chem; 1965 Mar; 240():1395-401. PubMed ID: 14284754
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic steatosis induced in C57BL/6 mice by a non-ß oxidizable fatty acid analogue is associated with reduced plasma kynurenine metabolites and a modified hepatic NAD
    Berge RK; Cacabelos D; Señarís R; Nordrehaug JE; Nygård O; Skorve J; Bjørndal B
    Lipids Health Dis; 2020 May; 19(1):94. PubMed ID: 32410680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenine pathway, NAD
    Castro-Portuguez R; Sutphin GL
    Exp Gerontol; 2020 Apr; 132():110841. PubMed ID: 31954874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in Kynurenine and NAD
    Wnorowski A; Wnorowska S; Kurzepa J; Parada-Turska J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biallelic variants in KYNU cause a multisystemic syndrome with hand hyperphalangism.
    Ehmke N; Cusmano-Ozog K; Koenig R; Holtgrewe M; Nur B; Mihci E; Babcock H; Gonzaga-Jauregui C; Overton JD; Xiao J; Martinez AF; Muenke M; Balzer A; Jochim J; El Choubassi N; Fischer-Zirnsak B; Huber C; Kornak U; Elsea SH; Cormier-Daire V; Ferreira CR
    Bone; 2020 Apr; 133():115219. PubMed ID: 31923704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of Tryptophan and Nicotinamide Adenine Dinucleotide in Immunity: A New Twist in an Old Tale.
    Rodriguez Cetina Biefer H; Vasudevan A; Elkhal A
    Int J Tryptophan Res; 2017; 10():1178646917713491. PubMed ID: 28659716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.